Clinical Trials in Houston

Showing 2441-2460 of 15,366 trials

Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans

NCT07187011

The purpose of this study is to test the drug PT150, which blocks glucocorticoid receptor (GR) signaling, for treatment of PTSD in Veterans, and establish a safety and efficacy profile that will inform the design of future studies.

PTSD - Post Traumatic Stress Disorder

San Diego Veterans Healthcare System120 participantsStarted Apr 2026

San Diego, California, United States • Houston, Texas, United States

Active Not RecruitingPhase 1/2< 1 mile

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

NCT04455841

This Phase 1/2, open-label, dose-finding study is intended to evaluate the safety and tolerability, PK, PD, and efficacy of INCB000928 administered as monotherapy or in combination with ruxolitinib in participants with MF who are transfusion-dependent or presenting with symptomatic anemia. This study will consist of 2 parts: dose escalation and expansion.

AnemiaPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis

Incyte Corporation84 participantsStarted Mar 2021

Duarte, California, United States • Irvine, California, United States • Los Angeles, California, United States +31 more locations

Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Find Trials by Condition in Houston

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

SP Thoracic IDE Study

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation